Literature DB >> 11782926

Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon.

Jean Ndjomou1, Bernd Kupfer, Bettina Kochan, Leopold Zekeng, Lazare Kaptue, Bertfried Matz.   

Abstract

Parenteral transmission of HCV is well established but other possible routes such as heterosexual transmission are still questioned. The Central African region is characterised by a high HCV endemicity without any evidence on the route of transmission. The information on HCV genotypes that circulate in this area is also limited and controversial. HIV infection is very frequent in this region and mostly acquired via the heterosexual route. The aim of this work was to investigate the trend of HCV infection and genotypes among HIV high-risk groups from Cameroon. Four hundred eighty-two patients including 229 tuberculosis clinic attendants, 184 sexually transmitted disease clinic attendants, and 69 HIV clinical suspects from another clinic were enrolled. All plasma samples were screened for antibodies to HCV and HCV RNA. Genotypes were assigned by sequencing a 5'UTR amplified fragment. The overall prevalence of HCV markers was 11.6% and a significant increasing trend with respect to age was observed. A proportion of 64.1% (34/53) of HCV antibody positive samples was viraemic. HCV RNA was found in 3 samples that were indeterminate in RIBA 3.0. One was negative in the antibody screening test and the two others were weakly positive. The data on HCV genotypes revealed that genotype 1 was involved in 57% of viraemias, genotype 2 in 24%, while genotypes 4 and 5a accounted for 16 and 3%, respectively. In contrary to the predominance of genotype 4 reported in some African countries and even the neighbouring countries, these data demonstrate clearly that HCV infection in Cameroon is dominated by genotypes 1 and 2. No association was found between the HCV markers and the presence of HIV infection. It is concluded, therefore, that the heterosexual route plays a minor role in HCV transmission in this country. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782926     DOI: 10.1002/jmv.2128

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Hepatitis C in Cameroon: What is the progress from 2001 to 2016?

Authors:  Borris Rosnay Tietcheu Galani; Richard Njouom; Paul Fewou Moundipa
Journal:  J Transl Int Med       Date:  2016-12-30

2.  Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae.

Authors:  Jan Felix Drexler; Annika Seelen; Victor Max Corman; Adriana Fumie Tateno; Veronika Cottontail; Rodrigo Melim Zerbinati; Florian Gloza-Rausch; Stefan M Klose; Yaw Adu-Sarkodie; Samuel K Oppong; Elisabeth K V Kalko; Andreas Osterman; Andrea Rasche; Alexander Adam; Marcel A Müller; Rainer G Ulrich; Eric M Leroy; Alexander N Lukashev; Christian Drosten
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

3.  Epidemiological profiles of human immunodeficiency virus and hepatitis C virus infections in Malian women: Risk factors and relevance of disparities.

Authors:  Nouhoum Bouare; Andre Gothot; Jean Delwaide; Sebastien Bontems; Dolores Vaira; Laurence Seidel; Paul Gerard; Christiane Gerard
Journal:  World J Hepatol       Date:  2013-04-27

4.  Prevalence of HIV and HCV infections in two populations of Malian women and serological assays performances.

Authors:  Nouhoum Bouare; Dolores Vaira; Andre Gothot; Jean Delwaide; Sebastien Bontems; Laurence Seidel; Paul Gerard; Christiane Gerard
Journal:  World J Hepatol       Date:  2012-12-27

5.  Hepatitis C virus (HCV) genotypes in the Caribbean island of Martinique: evidence for a large radiation of HCV-2 and for a recent introduction from Europe of HCV-4.

Authors:  Jenny Martial; Yoann Morice; Sylvie Abel; André Cabié; Christelle Rat; Frédéric Lombard; André Edouard; Serge Pierre-Louis; Philippe Garsaud; Odile Béra; Roger Chout; Emmanuel Gordien; Paul Deny; Raymond Césaire
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 6.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

7.  Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa.

Authors:  Daniel Candotti; Jillian Temple; Francis Sarkodie; Jean-Pierre Allain
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina.

Authors:  Noemí del Pino; José Raúl Oubiña; Francisco Rodríguez-Frías; Juan Ignacio Esteban; María Buti; Teresa Otero; Josep Gregori; Damir García-Cehic; Silvia Camos; María Cubero; Rosario Casillas; Jaume Guàrdia; Rafael Esteban; Josep Quer
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

9.  Risk factors and genotypes of hepatitis C virus infection in libyan patients.

Authors:  Wa Alashek; M Altagdi
Journal:  Libyan J Med       Date:  2008-12-01       Impact factor: 1.657

10.  Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa.

Authors:  Guy-Roger Ndong-Atome; Maria Makuwa; Richard Njouom; Michel Branger; Francoise Brun-Vézinet; Antoine Mahé; Dominique Rousset; Mirdad Kazanji
Journal:  BMC Infect Dis       Date:  2008-06-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.